Targeting a specific immune pathway to improve treatment for colorectal cancer
Targeting the IL-33/ST2 Pathway in Colorectal Cancer Immunotherapy
This study is looking at a specific immune pathway to see if it can make cancer treatments work better for people with colorectal cancer, and it may involve patients trying out new therapies that could improve their results.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Miami School of Medicine NIH-funded |
| Lab location | 1 site (Coral Gables, United States) |
| Project ID | NIH-11017737 on NIH RePORTER |
What this research studies
This research investigates the IL-33/ST2 immune pathway to enhance the effectiveness of immunotherapy in colorectal cancer patients. The approach involves understanding how this pathway interacts with existing treatments, particularly those targeting programmed cell death proteins. By utilizing advanced techniques in tumor immunology and bioinformatics, the research aims to identify new therapeutic strategies that could lead to better patient outcomes. Patients may be involved in trials that assess the safety and efficacy of these novel treatments.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with colorectal cancer who have not responded adequately to current immunotherapy treatments.
Not a fit: Patients with early-stage colorectal cancer or those who have not yet undergone immunotherapy may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective immunotherapy options for colorectal cancer patients, potentially improving survival rates.
How similar studies have performed: Previous research has shown promising results in targeting immune pathways for cancer treatment, indicating potential for success in this novel approach.
Where this research is happening
Coral Gables, United States
- University of Miami School of Medicine — Coral Gables, United States (Active)
Researchers
- Principal investigator: Van Der Jeught, Kevin — University of Miami School of Medicine
- Study coordinator: Van Der Jeught, Kevin
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.